CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 44 enrolled
Drug / intervention
Thermal Anisotropy Measurement Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05015751
NCT05015751N/ACompleted
CompareCT.gov

Assessment Of Flow In Cerebrospinal Fluid Shunts With A Wireless Thermal Anisotropy Measurement Device: Phase A

Rhaeos, Inc.·observational·Posted Aug 20, 2021·Updated Dec 19, 2024

In Brief

An observational study evaluating Thermal Anisotropy Measurement Device for Hydrocephalus. Completed, enrolled 44 participants across 4 sites.

Detailed Summary

This study evaluates the performance of a non-invasive thermal measurement device for assessing CSF shunt flow. Patients with an existing implanted shunt and symptoms of shunt malfunction will be evaluated with the study device.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHydrocephalus
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedAug 20, 2021
Enrollment StartAug 25, 2021
Primary CompletionJul 13, 2022
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 4.9 years ago

Interventions

Thermal Anisotropy Measurement Devicedevice

A wireless device for non-invasively assessing CSF shunt flow.